
Neurona is a cell therapy company focused on the development of breakthrough treatments for neurological disorders
Location: United States, California, South San Francisco
Employees: 51-200
Total raised: $192.6M
Founded date: 2008
Investors 4
Date | Name | Website |
- | UCB Ventur... | ucbventure... |
- | The Column... | thecolumng... |
08.03.2024 | Ysios Capi... | ysioscapit... |
- | SymBiosis | symbiosis.... |
Funding Rounds 4
Date | Series | Amount | Investors |
09.02.2024 | - | $120M | - |
22.06.2021 | - | $41.5M | - |
01.12.2015 | Series A | $23.5M | UCB Ventur... |
24.12.2014 | - | $7.6M | - |
Mentions in press and media 23
Date | Title | Description |
06.12.2024 | Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy Announced at 2024 Annual Meeting of the American Epilepsy Society | San Francisco, CA, December 6, 2024 – Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for epilepsy and other disorders of the nervous system, today announced positive clinical data from t... |
10.09.2024 | Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate | SAN FRANCISCO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that the California Institute for Re... |
12.03.2024 | Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days | SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced that Cory R. Nichol... |
12.03.2024 | Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days | - |
07.03.2024 | Neurona Therapeutics Announces Presentation of Updated Clinical Data at the Upcoming American Academy of Neurology (AAN) Annual Meeting from Lead Cell Therapy Candidate, NRTX-1001 | - |
09.02.2024 | Neurona Therapeutics Raises $120M in Funding | Neurona Therapeutics, a San Francisco, CA-based clinical-stage biotherapeutics company, raised $120M in funding. The round was led by Viking Global Investors and Cormorant Asset Management with participation from new and existing investors,... |
08.02.2024 | Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders | San Francisco, CA, February 8, 2024 – Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced the successful completion of a ... |
08.02.2024 | Neurona Therapeutics Lands $120M | SAN FRANCISCO, CA, Neurona Therapeutics today announced the successful completion of a $120 million financing. >> Click here for more funding data on Neurona Therapeutics >> To export Neurona Therapeutics funding data to PDF... |
08.02.2024 | Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders | - |
08.02.2024 | Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders | The financing, co-led by Viking Global Investors and Cormorant Asset Management with participation from The Column Group along with additional new and existing investors, follows promising early clinical data from NRTX-1001 epilepsy program... |
Show more